Genlong Xue
Dalian, 116021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The heterogeneity of dopamine-mediated vasodilation in human intrarenal arteries.
Journal: Journal of advanced research
Published: March 31, 2026
Breast tumour-secreted ADAM10 mediates atrial fibrogenesis and fibrillation.
Journal: European heart journal
Published: May 20, 2025
Binding of LncDACH1 to dystrophin impairs the membrane trafficking of Nav1.5 protein and increases ventricular arrhythmia susceptibility.
Journal: eLife
Published: January 08, 2025
Spexin Diminishes Atrial Fibrillation Vulnerability by Acting on Galanin Receptor 2.
Journal: Circulation
Published: May 10, 2024
Interdependent Nuclear Co-Trafficking of ASPP1 and p53 Aggravates Cardiac Ischemia/Reperfusion Injury.
Journal: Circulation research
Published: January 19, 2023
Benefits of SGLT2 inhibitors in arrhythmias.
Journal: Frontiers in cardiovascular medicine
Published: August 04, 2022
Sodium-Glucose cotransporter 2 inhibitor empagliflozin decreases ventricular arrhythmia susceptibility by alleviating electrophysiological remodeling post-myocardial-infarction in mice.
Journal: Frontiers in pharmacology
Published: July 07, 2022
Cullin-associated and neddylation-dissociated 1 protein (CAND1) governs cardiac hypertrophy and heart failure partially through regulating calcineurin degradation.
Journal: Pharmacological research
Published: March 31, 2022
Forced activation of dystrophin transcription by CRISPR/dCas9 reduced arrhythmia susceptibility via restoring membrane Nav1.5 distribution.
Journal: Gene therapy
Published: October 22, 2021
Transcription factor Meis1 act as a new regulator of ischemic arrhythmias in mice.
Journal: Journal of advanced research
Published: August 29, 2021
Cytoplasmic sequestration of p53 by lncRNA-CIRPILalleviates myocardial ischemia/reperfusion injury.
Journal: Communications biology
Published: July 30, 2021
Last Updated: 09/26/2026